Related Experiment Video
Updated: Oct 1, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Inhibitors of apoptosis proteins in prostate cancer cell lines
Kevin R McEleny1, R William G Watson, Ronan N T Coffey
1Department of Surgery, Mater Misericordiae Hospital, Conway Institute of Biomolecular and Biomedical Research, University College Dublin, 47 Eccles Street, Dublin 7, Ireland.
Background:
The caspases are the central executioners of apoptosis. The inhibitors of apoptosis proteins (IAPs) are a family of recently described caspase inhibitors. We hypothesised that tumor resistance to apoptosis could be due in part to IAP expression.
Methods:
The expression of NAIP, cIAP-1, cIAP-2, XIAP, and survivin was investigated in the prostate cancer cell lines LNCaP, PC3, and DU145. RNase protection assays and Western blotting were used to assess RNA and protein expression. Apoptotic susceptibility was determined using etoposide and assessed by propidium iodide (PI) DNA incorporation using flow cytometry.
Results:
DU145 and PC3 cells were more resistant to apoptosis than LNCaP cells. All the IAPs were identified in the cell lines with variation in IAP expression between different cell types. Immunohistochemistry demonstrated cIAP-1 expression in PC3 cells was nuclear, while the expression of cIAP-2 and XIAP was perinuclear. Growing LNCaP cells in charcoal-stripped or androgen-supplemented medium resulted in no alteration in IAP expression.
Conclusions:
This study characterises the expression of IAP in three of the most commonly used prostate cancer cells. IAP may make an important contribution to apoptotic resistance in patients with prostate cancer.
Insights
Inhibitors of apoptosis proteins (IAPs) are expressed in prostate cancer cells and may contribute to tumor resistance to apoptosis. This study investigated IAP expression in common prostate cancer cell lines.
Area of Science:
- Oncology
- Molecular Biology
Background:
- Caspases are key executioners of apoptosis.
- Inhibitors of Apoptosis Proteins (IAPs) are caspase inhibitors.
- Tumor resistance to apoptosis may involve IAP expression.
Purpose of the Study:
- Investigate IAP expression in prostate cancer cell lines.
- Determine the role of IAPs in apoptotic resistance.
Main Methods:
- Assessed expression of NAIP, cIAP-1, cIAP-2, XIAP, and survivin in LNCaP, PC3, and DU145 cells.
- Utilized RNase protection assays and Western blotting for RNA and protein analysis.
- Determined apoptotic susceptibility using etoposide and propidium iodide staining via flow cytometry.
Main Results:
- DU145 and PC3 cells exhibited greater apoptosis resistance than LNCaP cells.
- All investigated IAPs were detected, with varied expression levels across cell types.
- Immunohistochemistry revealed distinct localization patterns for cIAP-1, cIAP-2, and XIAP.
Conclusions:
- Characterized IAP expression in commonly used prostate cancer cell lines.
- IAP expression may significantly contribute to apoptotic resistance in prostate cancer.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Extrinsic Apoptotic Pathway
Abnormal Proliferation
Caspases